About: Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 March 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2007 (uk) im März 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 12 March 2007 (en) 2007 թվականի մարտի 12-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu en marzu de 2007 (ast)
publication date	wds:Q57384998-E9A66495-7BD3-4ABE-907C-06FB4E99C7C8
publication date	2007-03-12 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57384998-22B35F73-A3AE-461F-9811-6CCBC1E8F6A6
language of work or name	English
cites work	wds:Q57384998-08B72B02-067B-4AE5-9EBA-BE23BDB5725F wds:Q57384998-0D2FC18E-C246-4EF9-883A-83C32A8569FE wds:Q57384998-0FBE432C-D57D-4909-B94B-23FE5CAA6380 wds:Q57384998-147E91E9-9C39-4E37-AE17-D6FF10FBA068 wds:Q57384998-14BC317E-D933-4D75-BED2-30E6F9E707C8 wds:Q57384998-1A700274-481B-47E3-940C-C459834D51AA wds:Q57384998-22D83C71-251F-42E9-A635-2053F05042B4 wds:Q57384998-23C8D694-9F09-4F42-80F5-EE48802BC788 wds:Q57384998-284B69B4-32AD-4BC9-8D7B-D12DE3ED718E wds:Q57384998-2B317244-F529-4327-8841-469C7C2D5E87 wds:Q57384998-2D62F1A1-9D27-4EC3-B878-10A7A1B6822E wds:Q57384998-2F142DE5-A524-4EDB-B5C4-02FD3DE04CE3 wds:Q57384998-37A18C65-9064-4DFD-BDAE-1699C7459C95 wds:Q57384998-3FD3FF61-215B-4F75-A5AE-ED632FFE97B3 wds:Q57384998-40D622B3-3668-4704-82A6-540B2A568D70 wds:Q57384998-41FF0005-97BA-4F27-A34B-87F6A5AC8206 wds:Q57384998-42F37225-22CA-48D6-9ADF-B3A65BA1FA19 wds:Q57384998-4861648E-7631-4329-B03F-A99CDD4E03A8 wds:Q57384998-53C45D2D-F7B2-4832-A977-6BDCA9BBD02F wds:Q57384998-56FAC395-AA7F-4EAE-A775-3C938D7B2A9F wds:Q57384998-71A2D1E5-0BE6-437A-9A4F-B86E71708F3A wds:Q57384998-75F15E49-0489-4671-ADB1-E2C0B75F5023 wds:Q57384998-78D79D46-644B-450C-82B0-AE80474C3104 wds:Q57384998-859D9BD1-A9E1-4912-97D5-0B03689D1572 wds:Q57384998-8BA13A38-26A2-440E-AD21-9F08B1845CF0 wds:Q57384998-9B2C5294-B62F-4351-A59C-26F1E6429656 wds:Q57384998-9BF2A1A9-5BD2-4554-A05C-9F2FDCC19FD7 wds:Q57384998-C9E92D2E-B71B-42BB-99F9-8068E63F70E8 wds:Q57384998-CA43B082-C19A-40DB-BAA4-71036480CAC3 wds:Q57384998-CF562729-012D-4A82-AB1E-184459BAAE9D wds:Q57384998-D7E83E4F-6AAA-4E43-A45E-677FE55F9433 wds:Q57384998-D855F6ED-455C-401B-849A-0B0F57669279 wds:Q57384998-E17FB6D9-E9EE-4C32-9402-054F9EF231FC wds:Q57384998-F2B06567-C85C-437C-889B-D09241FE6712
cites work	Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults Immunogenicity of group A and group C meningococcal polysaccharides in human infants Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Priming for immunologic memory in adults by meningococcal group C conjugate vaccination Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial
author name string	wds:Q57384998-36D199AC-F9B8-4E49-820E-3FEF7167FFEE wds:Q57384998-47EFE55F-EF1B-41CB-A3B8-359E88CF66E4 wds:Q57384998-68A6649D-BCE1-4F92-AF4B-A27E5BED41CF wds:Q57384998-FB7A9406-074B-4229-B583-4533CF5C736B
author name string	Onchee Yu Jennifer C Nelson Barbara Carste Pat T Starkovich
rdfs:label	Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (en) Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (nl)
skos:prefLabel	Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (en) Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (nl)
name	Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (en) Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (nl)
author	wds:Q57384998-010A76F2-C6F1-4A94-99CF-DCB596B7C42D wds:Q57384998-1680F5F7-9910-4A20-A92C-B3A1E0CE1E4D wds:Q57384998-1B143940-28A7-41D3-AE77-451F776BB853 wds:Q57384998-3E4967BA-E0C5-43EC-9A9D-B0CD7328170A wds:Q57384998-3F787AB5-5CCD-4B81-AE0C-4FD43FF64251 wds:Q57384998-6C28EBCE-AB6A-4C5B-A33A-700AF314C6A5 wds:Q57384998-6F98C8CE-6978-4F67-B172-81892663C935

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software